We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Low-Value Preoperative Tests Remain Commonplace

By HospiMedica International staff writers
Posted on 23 Jun 2021
Routine testing before low-risk surgery has no known benefit, is overused and costly, and can lead to downstream care cascades, claims a new study. More...


Researchers at the University of Michigan (U-M; Ann Arbor, USA) conducted a study involving almost 40,000 patients who underwent low-risk, ambulatory surgical procedures in Michigan hospitals. The aim of the study was to examine the use of preoperative testing across diverse practice settings, assess inter-hospital and intra-hospital variations in testing, and identify determinants of testing in order to determine future targets for deimplementation strategies. The procedures selected included gall bladder removal, groin hernia repair, and cancerous breast tissue removal.

The results revealed that close to a third of the patients underwent two or more tests beforehand, and about 13% had three or more. The most common tests were a complete blood count, a basic metabolic panel, and an electrocardiogram (EEG). Patients who had a complete medical history and physical done during a visit that was separately billed were more likely to have had preoperative testing, as were those who were older or had co-morbidities. The data also revealed wide variations in testing between the 63 hospitals studied, but also within health systems. The study was published on May 17, 2021, in JAMA Internal Medicine.

“In the latter half of the 19th century, modern surgery was still in its infancy, anesthesia was new, and even minor surgeries were not routine. So researchers used tests to assess their patients' physical health and measure their risk of complications during operations,” said senior author Lesly Dossett, MD, PhD, of the division of surgical oncology. “There was probably a time when some of the testing did reduce adverse events. But now there have been so many advances in surgery, complication rates are so low that a lot of these tests are not necessarily helpful anymore.”

Common tests done before surgery include a chest X-rays, ECG, Urinalysis, a blood count that included white blood cells (WBCs), blood glucose, potassium, sodium, and other electrolytes, and coagulation studies (PT/PTT).

Related Links:
University of Michigan


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.